tiprankstipranks
Altamira Therapeutics (CYTO)
NASDAQ:CYTO
US Market

Altamira Therapeutics (CYTO) Technical Analysis

585 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Altamira Therapeutics’s (CYTO) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Altamira Therapeutics is a Sell.
Altamira Therapeutics’s (CYTO) 20-Day exponential moving average is 1.29, while Altamira Therapeutics’s (CYTO) share price is $1.04, making it a Sell.
Altamira Therapeutics’s (CYTO) 50-Day exponential moving average is 1.38, while Altamira Therapeutics’s (CYTO) share price is $1.04, making it a Sell.

Altamira Therapeutics (CYTO) Pivot Points

Jul 22, 2024, 05:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.19
1.25
1.29
1.35
1.39
1.45
1.49
Fibonacci
1.25
1.28
1.31
1.35
1.38
1.41
1.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Altamira Therapeutics (CYTO) Moving Averages

Jul 22, 2024, 05:36 PM
Period
Simple
Exponential
MA5
1.34Sell
1.30Sell
MA10
1.31Sell
1.30Sell
MA20
1.23Sell
1.29Sell
MA50
1.36Sell
1.38Sell
MA100
1.59Sell
1.73Sell
MA200
2.57Sell
2.89Sell
Altamira Therapeutics’s (CYTO) 10-Day exponential moving average is 1.30, while Altamira Therapeutics’s (CYTO) share price is $1.04, making it a Sell.
Altamira Therapeutics’s (CYTO) 100-Day exponential moving average is 1.73, while Altamira Therapeutics’s (CYTO) share price is $1.04, making it a Sell.
Altamira Therapeutics’s (CYTO) stock price is $1.04 and Altamira Therapeutics’s (CYTO) 50-day simple moving average is 1.36, creating a Sell signal.
Altamira Therapeutics’s (CYTO) stock price is $1.04 and Altamira Therapeutics’s (CYTO) 100-day simple moving average is 1.59, creating a Sell signal.
Altamira Therapeutics’s (CYTO) stock price is $1.04 and Altamira Therapeutics’s (CYTO) 200-day simple moving average is 2.57, creating a Sell signal.

Altamira Therapeutics (CYTO) Technical Indicators

Jul 22, 2024, 05:36 PM
Name
Value
Implied Action
RSI (14)
42.77
Neutral
STOCH (9,6)
60.97
Neutral
STOCHRSI (14)
66.03
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
16.97
Buy
Williams %R
-73.33
Buy
CCI (14)
29.58
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
44.32
Neutral
ROC
8.11
Buy
Altamira Therapeutics’s (CYTO) Relative Strength Index (RSI) is 42.77, creating a Neutral signal.
Altamira Therapeutics’s (CYTO) Trend Strength Indicator (ADX) is 16.97, creating a Buy signal.
Altamira Therapeutics’s (CYTO) Commodity Channel Index (CCI) is 29.58, creating a Neutral signal.
Altamira Therapeutics’s (CYTO) Price Rate of Change (ROC) is 8.11, creating a Buy signal.

FAQ

Is CYTO a Buy, Hold, or Sell?
Based on CYTO’s technical indicators, CYTO is a Sell.
    What is CYTO’s RSI (14)?
    CYTO’s RSI (14) is 42.77, which suggests CYTO is a Neutral.
      What is CYTO’s MACD?
      CYTO’s MACD is >-0.01, which suggests CYTO is a Sell.
        What is CYTO’s 5-day moving average?
        CYTO’s 5-day moving average is 1.34, which suggests CYTO is a Sell.
          What is CYTO’s 20-day moving average?
          CYTO 20-day moving average is 1.23, which suggests CYTO is a Sell.
            What is CYTO’s 50-day moving average?
            CYTO’s 50-day moving average is 1.36, which suggests CYTO is a Sell.
              What is CYTO’s 200-day moving average?
              CYTO’s 200-day moving average is 2.57, which suggests CYTO is a Sell.
                What is CYTO’s Williams % R (14)?
                CYTO’s Williams % R (14) is -73.33, which suggests CYTO is a Buy.
                  What is CYTO’s CCI (14)?
                  CYTO’s CCI (14) is 29.58, which suggests CYTO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis